Skip to main content
Top
Published in: Journal of General Internal Medicine 3/2018

01-03-2018 | Editorial

Overutilization of Breast Cancer Screening in the US: Awareness of a Growing Problem

Author: Mara A. Schonberg, MD, MPH

Published in: Journal of General Internal Medicine | Issue 3/2018

Login to get access

Excerpt

Recently, a 72-year-old female patient of mine with stage IV metastatic thyroid cancer came in for a routine visit, accompanied by her daughter. As we began to talk, the patient mentioned that the medical assistant (MA) who roomed her said that she needed a mammogram since she had not been screened in 2 years. Based on my patient’s thyroid cancer and other medical problems, I estimated her life expectancy to be <10 years. I told her that I did not think that she needed a mammogram due to the low likelihood of benefit and because there are risks to being screened. The patient was comfortable not having a mammogram, but her daughter still wanted her to have it done, though she has not yet scheduled the test. Ironically, the MA who recommended the mammogram was doing so in the name of “quality.” Receipt of biennial screening mammograms among women aged 50–74 years is a national quality metric, and my practice receives a financial incentive if nearly all (90%) women aged 50–74 are screened.1 To help achieve this goal, numerous systems are in place in our practice to ensure that as many women as possible are screened, including availability of same-day mammograms and training of MAs to identify and notify patients in need of screening. While these efforts result in more women being screened, they also lead to more screening in women who are unlikely to benefit, or low-value care.2
Literature
2.
go back to reference Harris RP, Wilt TJ, Qaseem A. A value framework for cancer screening: advice for high-value care from the American College of Physicians. Ann Intern Med 2015;162:712–7.CrossRefPubMed Harris RP, Wilt TJ, Qaseem A. A value framework for cancer screening: advice for high-value care from the American College of Physicians. Ann Intern Med 2015;162:712–7.CrossRefPubMed
5.
go back to reference Saslow D, Boetes C, Burke W, et al. American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin. 2007;57:75–89.CrossRefPubMed Saslow D, Boetes C, Burke W, et al. American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin. 2007;57:75–89.CrossRefPubMed
6.
go back to reference Bluemke DA, Gatsonis CA, Chen MH, et al. Magnetic resonance imaging of the breast prior to biopsy. JAMA. 2004;292:2735–42.CrossRefPubMed Bluemke DA, Gatsonis CA, Chen MH, et al. Magnetic resonance imaging of the breast prior to biopsy. JAMA. 2004;292:2735–42.CrossRefPubMed
7.
go back to reference Riggs KR, Ubel PA. The role of professional societies in limiting indication creep. J Gen Intern Med. 2015;30:249–52.CrossRefPubMed Riggs KR, Ubel PA. The role of professional societies in limiting indication creep. J Gen Intern Med. 2015;30:249–52.CrossRefPubMed
8.
go back to reference Siu AL. Screening for Breast Cancer: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med. 2016;164:279–96.CrossRefPubMed Siu AL. Screening for Breast Cancer: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med. 2016;164:279–96.CrossRefPubMed
9.
go back to reference Oeffinger KC, Fontham ET, Etzioni R, et al. Breast Cancer Screening for Women at Average Risk: 2015 Guideline Update From the American Cancer Society. JAMA. 2015;314:1599–614.CrossRefPubMedPubMedCentral Oeffinger KC, Fontham ET, Etzioni R, et al. Breast Cancer Screening for Women at Average Risk: 2015 Guideline Update From the American Cancer Society. JAMA. 2015;314:1599–614.CrossRefPubMedPubMedCentral
10.
go back to reference Ozanne EM, Drohan B, Bosinoff P, et al. Which risk model to use? Clinical implications of the ACS MRI screening guidelines. Cancer Epidemiol Biomarkers Prev. 2013;22:146–9.CrossRefPubMed Ozanne EM, Drohan B, Bosinoff P, et al. Which risk model to use? Clinical implications of the ACS MRI screening guidelines. Cancer Epidemiol Biomarkers Prev. 2013;22:146–9.CrossRefPubMed
11.
go back to reference Barratt A, Jorgensen KJ, Autier P. Reform of the National Screening Mammography Program in France. JAMA Intern Med. 2017. Barratt A, Jorgensen KJ, Autier P. Reform of the National Screening Mammography Program in France. JAMA Intern Med. 2017.
Metadata
Title
Overutilization of Breast Cancer Screening in the US: Awareness of a Growing Problem
Author
Mara A. Schonberg, MD, MPH
Publication date
01-03-2018
Publisher
Springer US
Published in
Journal of General Internal Medicine / Issue 3/2018
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-017-4258-9

Other articles of this Issue 3/2018

Journal of General Internal Medicine 3/2018 Go to the issue